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Polysaccharide Processing and
Presentation by the MHCII Pathway
pathogen-derived proteins to peptides and cleave Ii
away from MHCII, leaving an Ii-derived self-peptide
(CLIP) in the antigen binding groove of MHCII (Shi et al.,
Brian A. Cobb,1,2 Qun Wang,1,2
Arthur O. Tzianabos,1 Dennis L. Kasper1,2,*
1Channing Laboratory
1992, 1999). The acidic pH also activates HLA-DM toDepartment of Medicine
catalyze the exchange of CLIP for antigenic peptidesBrigham & Women’s Hospital
(Busch et al., 1998). Finally, the MHCII-peptide complexBoston, Massachusetts 02115
is shuttled to the cell surface where it is recognized by2 Department of Microbiology and
T cell receptors (TCRs) on CD4T cells, generatingMolecular Genetics
a specific immune response.Harvard Medical School
Adaptive MHCII-mediated CD4 T cell activation hasBoston, Massachusetts 02115
been considered to be strictly limited to protein antigens
(Watts and Powis, 1999). When presented to T cells by
MHCII, peptide antigens generally elicit a T cell-depen-Summary
dent immune response typified by the production of Th1
or Th2 cytokines as well as IgG and the induction ofThe adaptive immune system functions through the
immunologic memory. In contrast, the immunologic re-combined action of antigen-presenting cells (APCs)
sponse to polysaccharide antigens is considered T celland T cells. Specifically, class I major histocompatibil-
independent and characterized by a primary humorality complex antigen presentation to CD8 T cells is
immune response of IgM production, rare IgG classlimited to proteosome-generated peptides from intra-
switching, and no immunologic memory (Abbas et al.,cellular pathogens while the class II (MHCII) endocytic
2000). Vaccine research with carbohydrate-protein con-pathway presents only proteolytic peptides from ex-
jugates has demonstrated that attachment of sometracellular pathogens to CD4 T cells. Carbohydrates
polysaccharides or oligosaccharides to immunogenichave been thought to stimulate immune responses
carrier proteins like tetanus toxoid can generate an anti-independently of T cells; however, zwitterionic poly-
gen capable of inducing significant IgG production (Kas-saccharides (ZPSs) from the capsules of some bacte-
per et al., 1996), T cell activation, and immune memoryria can activate CD4 T cells. Here we show that ZPSs
specifically directed toward the carbohydrate (Baker etare processed to low molecular weight carbohydrates
al., 1999). However, no immunologic model exists thatby a nitric oxide-mediated mechanism and presented
describes T cell-dependent immune responses gener-to T cells through the MHCII endocytic pathway. Fur-
ated by carbohydrates in the absence of a carrierthermore, these carbohydrates bind to MHCII inside
protein.APCs for presentation to T cells. Our observations
In a rodent model of intraabdominal abscess forma-begin to elucidate the mechanisms by which some
tion, it was shown that the activation of CD4  T cellscarbohydrates induce important immunologic re-
by capsular polysaccharides is required for the modula-sponses through T cell activation, suggesting a funda-
tion of abscess formation (Tzianabos et al., 2001). Exper-mental shift in the MHCII presentation paradigm.
iments designed to study abscess formation resulting
from colonic perforation demonstrated that mice lackingIntroduction
CD4 T cells failed to develop abscesses in response
to purified polysaccharides with an adjuvant of sterilizedRecognition of foreign extracellular proteins by the
cecal contents (SCC) to mimic colonic leakage, yet
adaptive immune system begins with their entry into
transfer of naı¨ve CD4T cells into these animals restored
professional APCs (i.e., dendritic cells, macrophages,
the animal’s ability to develop abscesses in response
and B cells) and depends upon antigen processing to polysaccharides and SCC (Chung et al., 2003). Poly-
through the MHCII endocytic pathway and subsequent saccharide-mediated T cell activation can also be mea-
presentation to CD4 T cells (Watts and Powis, 1999). sured in vitro by monitoring T cell proliferation (Tzia-
Most pathogens initially undergo endocytosis by the nabos et al., 2000) or production of cytokines such as
APCs and are subsequently killed by oxidant molecules IL-2, IL-10, and interferon  (Tzianabos et al., 1999).
(e.g., superoxide and nitric oxide) produced during the Furthermore, CD4 T cells activated by polysaccharides
oxidative burst (Forman and Torres, 2001). Endosomes in vitro induce abscesses when given intraperitoneally
carrying released proteins then move through the vesic- with adjuvant; however, intravenous transfer of these
ular traffic, fusing with acidic lysosomes carrying host same activated T cells without adjuvant conferred pro-
proteases (Watts, 1997). These endo/lysosomes subse- tection against abscesses induced by viable bacteria
quently fuse with exocytic vesicles, forming the MHCII (Tzianabos and Kasper, 2002). These studies estab-
compartment (MIIC). Exocytic vesicles originate in the lished that some polysaccharides can activate CD4
trans-Golgi network and contain proteins such as the T cells in vivo and in vitro.
MHCII protein HLA-DR, accessory proteins like the MHCII Chemical characterization of several polysaccharides
bound invariant chain (Ii), and HLA-DM (Watts, 1997). able to activate T cells has shown that the common
Within the MIIC, the lysosomal proteases process the characteristic is the presence of a zwitterionic charge
motif within the repeating unit. These zwitterionic poly-
saccharides (ZPSs) are inactivated by chemical modifi-*Correspondence: dennis_kasper@hms.harvard.edu
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cations that eliminate the alternating charge character coating the surface (not shown). In addition, significant
of the carbohydrate. Conversely, neutral or negatively surface and intracellular regions of colocalization indi-
charged polysaccharides do not show an ability to acti- cated that ZPS and MHCII proteins colocalize intracellu-
vate T cells or facilitate abscess formation, yet if chemi- larly as well as on the plasma membrane (Figure 1A,
cally altered to be zwitterionic, this immunologic activity arrowhead and arrows, respectively). In order to elimi-
is created (Tzianabos et al., 1993). NMR structural stud- nate the possibility that these observations were limited
ies of ZPSs such as polysaccharide A (PS-A) from to cultured Raji cells, human peripheral blood mononu-
B. fragilis and the capsular polysaccharide from type 1 clear cells (PBMCs; Figure 1B) and mouse splenocytes
Streptococcus pneumoniae (Sp1) reveal the formation (not shown) were also used to demonstrate colocaliza-
of extended right-handed helices in solution (Wang et tion of MHCII and PS-A. Control studies with ovalbumin
al., 2000; Choi et al., 2002). These helices have repeated showed both entry and surface colocalization with
15 A˚ negatively charged grooves whose lateral bound- MHCII, yet neutral and negatively charged polysaccha-
aries are occupied by the charges, with the positive ride controls showed entry but failed to colocalize on
charges located on the outer surfaces. The molecular the surface with MHCII (not shown).
weight (MW) of ZPSs has been shown to impact antige- Endosomes are known to fuse with lysosomes as well
nicity in that ZPSs of 5 kDa appear to poorly activate as exocytic vesicles from the trans-Golgi network car-
T cells, while those of15 kDa activate to equal extents rying the MHCII machinery in the established MHCII
(Kalka-Moll et al., 2000). These studies collectively sug- pathway (Watts, 1997); however, the involvement of
gest that the epitope in abscess-inducing ZPSs is both these vesicles in the trafficking of ZPS antigens was not
structural and electrostatic in nature. known. Using mAbs to the lysosomal marker LAMP-1
In vitro T cell activation assays with fixed APCs fail to (D’Souza and August, 1986) and the exocytic vesicle
activate T cells; thus, like a conventional protein antigen, marker HLA-DM (Sanderson et al., 1994), we found that
ZPS molecules require entry into the APC (Brubaker PS-A colocalized with both LAMP-1 (Figure 1C) and
et al., 1999). It was further demonstrated that T cell HLA-DM (Figure 1D) inside the cells.
activation by ZPS molecules requires endo/lysosomal Endocytosis and phagocytosis are processes that re-
acidification in addition to the MHCII protein HLA-DR— quire cytoskeletal rearrangements and polymerization.
but not HLA-DP, HLA-DQ, or any of the MHC class I
In order to distinguish passive entry across or through
molecules (Kalka-Moll et al., 2002). Given that acidic
membrane proteins from classical endocytosis, drugs
intravesicular pH is required for protease activity and
known to inhibit cytoskeleton polymerization were used.
invariant chain (Ii) cleavage (Shi et al., 1992, 1999), HLA-
Raji cells were first treated with either cytochalasin DDM activity (Busch et al., 1998), and HLA-DR antigen
to block actin polymerization (Figure 1E, left) or colchi-binding activity (Rotzschke et al., 2002), these data raise
cine to block microtubule polymerization (Figure 1E,the possibility that ZPS-mediated T cell activation oc-
middle) and then incubated with PS-A and stained withcurs via the conventional MHCII endocytic pathway.
mAbs to HLA-DR. As previously seen for conventionalIn this report, we describe the pathway utilized by
protein antigens (Bacci et al., 1996; Svensson et al.,ZPS antigens to activate T cells. Our results indicate
1997), both of these inhibitors significantly reduced thethat PS-A is endocytosed by APCs and localizes to the
endocytosis of PS-A (Figure 1E, right).conventional MIIC. Biochemical, coimmunoprecipita-
Another key step in the established MHCII pathwaytion (co-IP), and animal studies demonstrate ZPS pro-
is the acidification of the MIIC vesicle, which is requiredcessing through oxidation by nitric oxide (NO). We fur-
to free the peptide binding site on MHCII proteins (Rib-ther show that PS-A requires entry, MIIC acidification,
erdy et al., 1992; Sloan et al., 1995). To assess the impactprocessing, and MHCII expression for presentation by
of acidification on ZPS progress in the endocytic path-B cells and T cell engagement via interactions with
way, Raji cells were treated with either bafilomycin A1TCRs. Finally, we present data that demonstrate that
(BFA; Figure 1F, left), an inhibitor of the ATPase protonPS-A binds to MHCII in a pH-, HLA-DM-, and pro-
pump, or chloroquine (Figure 1F, middle), which bufferscessing-sensitive manner. These data form the basis
the vesicles and prevents acidification indirectly. Similarfor a substantial broadening of the paradigm of MHCII
to conventional antigens, we found that these treat-processing and presentation to include non-protein anti-
ments did not reduce the amount of ZPS endocytosedgens and oxidative antigen processing.
or the colocalization of ZPS with MHCII proteins within
the MIIC compartment (Figure 1F, right).Results
Although MHCII and PS-A colocalization was ob-
served, it was not clear whether this was due to fusionPolysaccharide Antigens Are Taken into the MHC
of exocytic vesicles with endo/lysosomes or to entry ofClass II Endocytic Pathway
the PS-A-loaded vesicles into the ER through an un-To understand the role of the MHCII endocytic pathway
known mechanism. These possibilities were examinedin polysaccharide-mediated T cell responses, we stud-
in cells treated with brefeldin A, which blocks traffickingied ZPS trafficking in APCs. Using confocal microscopy
between the Golgi apparatus and the ER, with the netwith human Raji B cells, we found significant amounts
effect of trapping proteins inside the ER following theirof PS-A both inside and on the surface of APCs (Figure
synthesis (Adorini et al., 1990). We found that uptake of1A). Time course studies indicated that entry and sur-
PS-A was not significantly affected, yet MHCII and PS-Aface localization of PS-A was visible in 30 min and
colocalization was reduced (Figure 1G, left) in a dose-peaked at 6 hr (not shown), while Z axis optical slices
confirmed that the PS-A signal is both inside the cell and dependent manner (Figure 1G, right).
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Figure 1. Trafficking of ZPS Antigens
Fluorescent antigens (red) were incubated with APCs and then with fluorescent mAbs against host markers (green). Yellow signal indicates
colocalization. White bars indicate 10 m.
(A) PS-A in Raji cells stained for HLA-DR, showing internal (arrow heads) and surface (arrows) colocalization.
(B) Primary human MNCs with PS-A and HLA-DR colocalized (arrows).
(C) Raji cells with PS-A and LAMP-1 colocalized (yellow).
(D) Raji cells with PS-A and HLA-DM with colocalization (yellow).
(E) Raji cells with the actin inhibitor cytochalasin D (left) or the microtubule inhibitor colchicine (middle) reduced PS-A uptake and HLA-DR
colocalization (p  0.0001; right).
(F) Raji cells with either bafilomycin A1 (left) or chloroquine (middle) showing no significant change (p 	 0.7852) in PS-A/HLA-DR colocaliza-
tion (right).
(G) Raji cells with brefeldin A (20 g/ml; left). Intracellular and surface colocalization is impaired (p  0.0001; right), yet uptake of antigen is
not altered.
Polysaccharide Antigens Are Partially cell lines depolymerized PS-A from 
100 kDa to a MW
of about 15 kDa (Figure 2A, arrow). This observationDepolymerized inside Endocytic Compartments
Protein antigens are digested by acid-activated prote- was confirmed in primary mouse splenocytes, THP-1
monocytes, and B1 B cells (not shown). The low MWases in the MIIC vesicle for peptide generation and load-
ing onto MHCII for presentation. In order to determine radioactive polysaccharide recovered was immunopre-
cipitated with specific serum, which demonstrated thatif ZPS molecules are also processed, B cells (Raji and
M12) were incubated with [3H]-PSA overnight, then the both the high and low MW PS-A were recognized to the
same degree (not shown).microsomal fractions of the cells were analyzed to mea-
sure the MW of recovered PS-A. We found that both Elucidation of the mechanism for PS-A processing
Cell
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Figure 2. Polysaccharide Processing
EV is the elution volume in ml.
(A) [3H]-PSA isolated from Raji (red) or M12 (blue) B cell endosomes analyzed by Superose 12 chromatography. Control PS-A (black) eluted
at the void volume of the column (MW 
100 kDa). PS-A isolated from either B cell line showed both high and low (arrow; 15 kDa) MW
fragments and retained recognition by PS-A mAbs (not shown).
(B) [3H]-PSA incubated with Raji endo/lysosomal lysates (blue) and control [3H]-PSA (red) analyzed by Superose 12, showing no enzymatic
cleavage.
(C) The same endo/lysosomal lysates (E) show acid-stable protease activity unlike trypsin (T). Red and blue bars indicate assays performed
at pH 5.0 and pH 7.3, respectively. Data were normalized to the pH 7.3 activity.
was first explored through the use of microsomal ly- oxidase enzyme responsible for generating superoxide
(CGD or chronic granulomatous disease model [Pollocksates. The possibility of glycosidase activity was mea-
sured with lysate-treated [3H]-PSA under neutral and et al., 1995]), and mice lacking inducible NO synthase
(iNOS/; Laubach et al., 1995) to develop abscessesacidic conditions. Using Superose 12 chromatography,
we found no detectable processing activity in any of against both B. fragilis and purified PS-A with SCC adju-
vant. WT mice developed abscesses in response to ei-the assayed lysates (Figure 2B), yet these same lysates
consistently showed acid-stable protease activity (Fig- ther live B. fragilis bacteria or purified PS-A but not in
response to adjuvant alone (Figure 4A). When chal-ure 2C).
Next, the effects of the environmental conditions lenged with B. fragilis, significantly fewer CGD and
iNOS/ mice developed abscesses than WT. However,found along the endocytic pathway on PS-A were stud-
ied. As summarized in Figure 3A, we found that neither when injected with purified PS-A, 100% of the CGD
mice developed abscesses (Figure 4A) that were notablylow pH (4.5 to 5.0) nor reducing conditions (2-mercapto-
ethanol) had a measurable effect on PS-A. However, larger than those formed in WT animals (not shown),
whereas most iNOS/ mice failed to form abscessesoxidation with H2O2 at pH 7.3 but not 5.0 (Figure 3B)
reduced the size of PS-A, albeit to a somewhat larger (Figure 4A). Next, intact PS-A was compared to O3-
cleaved PS-A (15 kDa) in abscess induction studiesMW than APC-processed PS-A (Figure 2A, arrow). Fur-
thermore, NaIO4 (Figure 3C) as well as O3 (Figure 3D) with WT and iNOS/ mice. Although the intact PS-A
did not induce abscesses in the iNOS/mice, the abilitytreatments were more effective at PS-A depolymeriza-
tion, yielding polysaccharides that were the same MW to elicit a T cell response leading to abscess formation
was restored when O3-cleaved PS-A was used (Figureas those found inside APCs (Figures 3C and 3D, arrows).
Like H2O2, the NaIO4 treatment worked best at pH 7.3, 4B). No significant difference was seen between WT and
iNOS/ mice with O3-cleaved PS-A (p 	 0.6469).and O3 treatment produced low MW PS-A in only 5 min
(not shown), although reduction to15 kDa was optimal
at 1 hr (Figure 3D). Presentation of Polysaccharide Antigens Is
Dependent upon MHC Class II ProteinsTo determine whether oxidation plays a significant
role in ZPS processing in vivo and whether that pro- The cellular requirements to achieve ZPS uptake and
presentation were further explored with confocal mi-cessing is required for T cell activation, we compared
the ability of WT C57BL/6, mice lacking the NADPH croscopy. Pixel histograms of Raji cells incubated with
Figure 3. In Vitro ZPS Cleavage
Superose 12 elution profiles.
(A) pH (red) and 2-mercaptoethanol (blue) effects on PS-A MW. At both pH 5.0 (open circles) and 7.3 (solid circles), no change in MW was seen.
(B) 10% H2O2 at pH 5.0 (red) and pH 7.3 (blue) compared to control PS-A (black), showing only modest cleavage at pH 7.3 (MW 

 15 kDa).
(C) PS-A cleavage (MW  15 kDa; arrow) was seen with 1 mM NaIO4 at pH 7.3 (blue), but not at pH 5.0 (red) or in the control (black).
(D) PS-A was treated by ozone gas for 0 (black), 30 (red), and 60 (blue) min, with most PS-A reduced to 15 kDa (arrow) after 60 min.
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Figure 4. Abscess Formation
(A) Abscess induction in WT (gray), iNOS/
(red), and CGD (blue) mice with either PBS,
108 live B. fragilis, or 50 g PS-A with SCC
adjuvant. Values listed are the number of ab-
scess-positive animals per total. WT mice
formed abscesses in response to both bacte-
ria and purified PS-A whereas neither mutant
developed abscesses against live bacteria.
The CGD but not iNOS/ mice formed ab-
scesses against intact PS-A.
(B) WT (gray) and iNOS/ (red) mice were challenged with intact or ozone-cleaved PS-A and SCC. Pre-cleavage of PS-A by ozone restored
abscess formation in iNOS/ mice. No significant difference with cleaved PS-A was seen in WT and iNOS/ animals (p 	 0.6469).
ZPS illustrate both the surface and intracellular PS-A MHCII, and TCR (Figures 6D–6F, arrows). No engage-
ment was seen in cells from naı¨ve mice (not shown).(Figure 5A). These results were compared with those for
Raji cells lacking MHCII expression (RJ2.2.5), Raji cells
treated with colchicine, and Raji cells treated with BFA Discussion
to determine the effects on surface localization. The
RJ2.2.5 cells endocytosed PS-A, yet failed to present it The Endocytic Pathway for
Polysaccharide Antigenson the cell surface (Figure 5B). Colchicine treatment of
Raji cells blocked endocytosis of PS-A and prevented The current paradigm for exogenous antigen presenta-
tion states that only proteins are taken into the endocyticsignificant surface presentation (Figure 5C), while BFA
blocked presentation but not uptake (Figure 5D). To pathway of APCs, localized to MIIC vesicles, processed
by acid-activated proteases, exchanged onto MHCIIconfirm a direct interaction between ZPS and MHCII
molecules, two approaches were taken. First, in vitro proteins with the help of HLA-DM, and presented to
T cells on the APC surface (Watts, 1997). Furthermore,binding studies were performed with soluble HLA-DR2
protein and biotinylated ZPS molecules. At pH 5.0 (Fig- polysaccharides are believed to be T cell-independent
antigens. However, this mechanism does not accounture 5E) and 7.3 (not shown), no detectable intact PS-A
(100 kDa) bound to HLA-DR2 either with or without for the observations with ZPS antigens in that they elicit
an MHCII-dependent CD4 T cell response that resultsHLA-DM. However, processed PS-A (15 kDa) did bind
to HLA-DR2 in the presence of HLA-DM, and this effect in abscess formation (Tzianabos et al., 2000; Kalka-Moll
et al., 2002). The current model for MHCII presentationwas reduced at pH 7.3 (Figure 5E). Second, co-IP experi-
ments were performed using [3H]-PSA with WT and does not explain these conflicting observations.
In the present report, we have shown that ZPS anti-iNOS/ splenocytes and mAbs to MHCII to confirm
that the in vitro binding data accurately reflect cellular gens behave remarkably similar to conventional protein
antigens within the MHCII presentation pathway. First,presentation of PS-A and to correlate the abscess stud-
ies (Figure 4) with direct observations. Low MW PS-A endocytosis of PS-A was shown to be exquisitely con-
trolled by cytoskeletal rearrangements. The specificityantigen was observed in MHCII immunoprecipitates
from WT cells, yet the iNOS/ cells failed to present of this endocytosis and the possibility of receptor pro-
teins remain unclear, although PS-A uptake by RJ2.2.5significant amounts of antigen (Figure 5F). Controls with
LAMP-1 mAbs failed to co-IP PS-A, and SDS-treated cells and brefeldin A-treated Raji cells rules out MHCII
and other ER-synthesized proteins as ZPS receptors.PS-A controls showed no significant change in elution
profile (not shown). The failure of iNOS/ cells to pres- Nonetheless, nonspecific pinocytosis could be involved
and thus the lack of T cell activation by neutral or singlyent PS-A antigen was probed further using co-IP from
WT and iNOS/ cells incubated with both high and low charged polysaccharides (Tzianabos et al., 1993) likely
reflects a lack of presentation or recognition rather thanMW PS-A (Figure 5G). Both cell populations presented
low MW PS-A on MHCII molecules. The size of the PS-A entry. Moreover, the delivery of lysosomal and exocytic
vesicle contents to the endosome carrying ZPS antigensprecipitated was indistinguishable from that of the pro-
cessed PS-A found inside APCs (Figure 2A). to form the MIIC vesicle has been demonstrated. Al-
though these data effectively eliminate the possibility of
an alternate ZPS presentation pathway in APCs, thePolysaccharide Antigens Induce APC/T Cell
Engagement through MHCII entry mechanism differences between purified ZPS anti-
gen and encapsulated bacteria during an infection re-and TCR Proteins
The final step in the ZPS antigen pathway was analyzed main to be elucidated.
We also document processing of ZPS antigens prior toby confocal microscopy in which mouse splenocytes
from ZPS-treated mice were incubated without antigen, presentation by MHCII. Previous reports demonstrated
that very small ZPS antigens (5 kDa; 5 repeatingunlabeled PS-A, or a superantigen control and visualized
using mAbs against MHCII and TCRs to detect APC/T units) failed to activate T cells and induce abscess for-
mation in mice, strongly suggesting a structural compo-cell engagement. Without antigen (Figure 6A), no signifi-
cant engagement was observed, yet the addition of unla- nent to the immunogenicity of ZPS molecules beyond
the zwitterionic charge motif of the repeating unit (Kalka-beled PS-A (Figure 6B) or superantigen (Figure 6C) in-
duced engagement (2% and
10%, respectively). The Moll et al., 2000). Interestingly, our binding, co-IP, and
abscess induction results show that ZPS antigens mustidentity of the presented molecule was confirmed using
fluorescent PS-A, yielding white colocalization of PS-A, be processed to approximately 12–15 kDa (15 re-
Cell
682
Figure 5. MHC-Dependent Presentation
White bars indicate 10 m in each image and PS-A is red.
(A) PS-A with Raji cells, showing surface and internal PS-A. A pixel histogram shows the localization of PS-A.
(B) PS-A was incubated with RJ2.2.5 cells (MHCII/ Raji cells) demonstrating that the lack of MHCII does not alter PS-A uptake but nearly
eliminates surface-localized PS-A.
(C) PS-A with colchicine-treated Raji cells, showing that treatments results in an amount of surface PS-A comparable to that on RJ2.2.5 cells,
but much less than untreated cells.
(D) PS-A with BFA-treated Raji cells. Uptake is unchanged, but surface localization is significantly reduced.
(E) Purified HLA-DR2 binding with either intact PS-A (iPSA) or 15 kDa PS-A (pPSA). The x axis indicates the ligand and pH. No binding is seen
without HLA-DR2 (red), without HLA-DM added (blue), or with iPSA, yet pPSA was able to bind in a pH- and HLA-DM-sensitive manner (green).
(F) Intact PS-A co-IP with MHCII mAbs from WT and iNOS/ splenocytes. Superose 12 analysis (EV 	 elution volume) revealed that low MW
PS-A was bound to cellular MHCII molecules from WT (red) but not iNOS/ (blue) cells. No PS-A was precipitated with LAMP-1 mAbs (black).
(G) A mixed MW population of PS-A co-IP with MHCII mAbs from WT and iNOS/ splenocytes. Superose 12 analysis shows that both WT
(red) and iNOS/ (blue) cells exclusively bound and presented low MW PS-A. (F) and (G) show CPM values normalized to the highest WT count.
peating units) for presentation. Combined with the near-neutral pH but not at the acidic pH found later in the
endocytic pathway; the implication is that if oxidationglobal helical conformation of ZPSs observed by NMR
(Choi et al., 2002), these observations collectively sug- is the primary mechanism of ZPS processing, it must
precede vesicular acidification.gest that these molecules must be long enough to main-
tain their helical conformation but small enough to allow With the involvement of oxidants, our model also fits
well into the events surrounding the oxidative burst thatstable binding to MHCII and recognition by TCRs
without masking important protein-protein contacts. accompanies phagocytosis of microbes. Upon uptake,
APCs are known to produce large amounts of reactiveInterestingly, no glycosidase activity capable of de-
polymerizing PS-A has been identified, yet we found that oxygen species (ROS) and reactive nitrogen species
(RNS) that facilitate bacterial killing (Forman and Torres,chemical oxidation by a number of oxidants effectively
cleaved PS-A. Glycosidase enzymes are known to be 2001). Experiments using the abscess induction model
to measure in vivo T cell activation in superoxide-defi-very specific (Rye and Withers, 2000; Davies and Henris-
sat, 1995), yet all ZPS molecules, such as the type 8 cient (Pollock et al., 1995) and NO-deficient mice (Lau-
bach et al., 1995) have yielded insights into the roles ofcapsule from S. aureus and Sp1, activate T cells in a
manner indistinguishable from PS-A (Tzianabos et al., these oxidation pathways. We found that ROS-deficient
mice did not develop abscesses following live bacterial1994, 2001). The use of a general processing mechanism
via oxidation therefore fits well with the hypothesis that challenge, supporting the traditional notion that ROS
oxidation plays a bactericidal function (Pollock et al.,other ZPSs are also processed despite significant mono-
saccharide and linkage differences. In addition, the 1995). The killing of organisms results in liberation of
their surface polysaccharides and internal proteins,cleavage of PS-A by oxidation was possible only at a
Polysaccharide Processing and MHCII Presentation
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Figure 6. Immune Synapse Formation
Mouse splenocytes incubated with or without antigen and then stained for MHCII (red) and TCR (green). White bars indicate 10 m in each
image. No APC/T cell engagement was seen in the absence of antigen (A); however, after incubation with unlabeled PS-A (B) or unlabeled
superantigen (C), cells formed yellow immune synapses (arrows). (D) Tricolor analysis shows white trilocalization of PS-A (blue), MHCII (red),
and TCR (green) under the same conditions. (E) Magnification of (D) with colocalization (arrows). (F) Separate color channel images of (D)
for clarity.
making these molecules available for processing and acidification inhibits ZPS-mediated T cell activation
(Kalka-Moll et al., 2002), therefore if processing of ZPSpresentation. Consistent with this hypothesis was the
robust abscess-inducing response mounted by ROS- molecules requires near-neutral pH and is not depen-
dent upon enzymatic activity, then acidification mustdeficient mice challenged with purified PS-A and SCC
adjuvant. In contrast, mice lacking NO failed to form remain critical for other reasons. It is conceivable that
protease activity is still important because of the actionabscesses when challenged with either live bacteria or
large MW PS-A (both containing SCC), implying that NO of cathepsin S and its role in Ii cleavage (Riese et al.,
1998). This cleavage event is essential to allow antigenicproduction is important not only for killing but also for
molecular cleavage of capsular components. This possi- peptides to bind MHCII for presentation. In addition, the
function of the exchange factor HLA-DM is pH sensitivebility was explored in experiments which showed that
iNOS/ animals developed abscesses in response to in that it requires a low pH for activity (Busch et al.,
1998). Without Ii cleavage and peptide exchange, thelow MW “pre-processed” PS-A with SCC. What’s more,
recent evidence shows that patients lacking superoxide binding groove on MHCII is not available to conventional
antigens. In ongoing studies, we have found that knock-produce significantly more NO than normal in response
to inflammatory signals (Tsuji et al., 2002), providing out mice lacking H2-M (murine HLA-DM homolog) do not
develop abscesses when challenged with ZPS (D.L.K.,an explanation as to why the CGD mice responded so
strongly (100% formed abscesses) to intact ZPS chal- unpublished data). The present data suggest that ZPS
molecules require Ii cleavage and CLIP exchange bylenge. These observations have led us to five conclu-
sions. First, iNOS/ mice have not lost the intrinsic HLA-DM in order to free the necessary binding site for
ZPS antigens. The implication is that ZPS and CLIPability to form abscesses in response to the appropriate
stimuli. Second, iNOS/ mice are incapable of pro- peptide binding to MHCII appear to be mutually ex-
clusive.cessing PS-A for MHCII presentation. Third, the ROS
and RNS pathways are not redundant in their contribu- One major difference between superantigens and
conventional antigens is the requirement for endocytiction to ZPS uptake, processing, and presentation.
Fourth, the activation of T cells occurs by ZPS presenta- pathway. Superantigens merely bind to MHCII proteins
on the surface of the APC, where they are recognizedtion and is not a result of contaminating peptides, which
can be presented by iNOS/ mice. Finally, these results by TCR proteins on T cells (Kappler et al., 1994).
Conventional antigens, however, require passage throughdemonstrate conclusively that ZPS processing is neces-
sary for T cell activation in vivo. the endocytic pathway in order to be processed and
loaded onto MHCII inside the cell prior to surface expo-After oxidative processing and the formation of the
MIIC, the vesicles undergo acidification (Watts, 1997). sure and T cell recognition (Watts, 1997; Watts and
Powis, 1999). Our confocal data demonstrate that with-Previous reports have demonstrated that blockade of
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link for the cellular and in vitro processing data, the
animal abscess results, and the quantitative in vitro
binding data. In fact, these results provide a logical
biochemical explanation for the abscess induction re-
sults by showing that only low MW ZPS can be pre-
sented by MHCII proteins, that NO is required to accom-
plish this processing, and that this defect can be
overcome by pre-processing of the input ZPS antigen.
Lastly, we show T cell and APC engagement in direct
response to PS-A presentation by APCs via interactions
with MHCII and TCRs, confirming that the alternate
CD1/TCR pathway is not involved with ZPS immune
responses. These data collectively demonstrate a direct
and functional interaction between MHCII, NO-pro-
cessed ZPS molecules, and TCRs that leads to T cell
activation and abscess formation.
The Model and Its Implications
This report documents ZPS oxidative processing and
the use of the MHCII endocytic pathway by a non-protein
antigen prior to its presentation and recognition. We
therefore propose a model to illustrate our findings inFigure 7. MHCII Pathway Model for ZPS Antigens
the context of the known MHCII endocytic pathway (Fig-Schematic model illustrating the key steps in the ZPS/MHCII path-
ure 7).way. [1] Extracellular antigens are endocytosed for presentation
through a cytoskeleton-dependent mechanism. [2] Cells undergo One particular area of impact of our findings is the
an oxidative burst, including the production of NO. NO and poten- role of NO in host immune responses. Production of
tially other oxidants process the antigen to low MW polysaccharides. NO has been shown to be important in many situations
[3] Endosomes fuse with resident lysosomes. [4] The MHC proteins
in vivo, ranging from neurotransmission (Koh et al., 2001)HLA-DR, HLA-DM, and Ii are assembled in the ER, transported
to vasodilation (Edmunds and Marshall, 2003). Manythrough the Golgi apparatus, and then budded into exocytic vesi-
studies have demonstrated that loss of NO productioncles. [5] Antigen-rich endo/lysosomes fuse with exocytic vesicles,
creating the MIIC vesicle carrying HLA-DR, HLA-DM, LAMP-1, and during inflammation can lead to immune suppression
antigen. MIIC acidification activates proteases responsible for pro- and an increase in bacterial infections (Gantt et al.,
cessing protein antigens and cleavage of Ii, thus permitting the HLA- 2001). Our results show that absence of NO production
DM-mediated antigen exchange of CLIP. [7] Processed antigens
during inflammation would be inhibitory to T cell activa-are loaded onto MHC with the help of HLA-DM and then shuttled
tion by carbohydrate antigens, which may in part explainto the cell surface for recognition by TCRs. [8] ZPS molecules
some of the alterations in immunity seen during inflam-mediate APC/T cell engagement through TCR recognition.
mation.
Due to the fact that many extracellular pathogens have
out entry into B cells, PS-A does not accumulate on carbohydrate surfaces, the ability of ZPS molecules to
the cell surface, which agrees with the previous reports activate T cells through MHCII presentation offers signif-
showing that fixed APCs fail to activate T cells with ZPS icant opportunities for the design of new classes of
antigens (Brubaker et al., 1999). In addition, HLA-DM vaccines against a variety of infectious diseases. Inter-
inhibition or a lack of MHCII expression results in uptake estingly, the ability of ZPSs to utilize this pathway for
without presentation. These data solidify the importance presentation to T cells may begin to explain why immuni-
of MHCII expression, the removal of peptides from the zation of humans with some polysaccharide vaccines
MHCII binding groove, and the general requirement for elicits a significant IgG response (Pier and Elcock,
PS-A to enter the APC. However, confocal microscopy 1984)—a result that does not fit the paradigm of T cell-
and immunogold-EM (Kalka-Moll et al., 2002) colocaliza- independent IgM production. Indeed, the present study
tion studies lack the necessary resolution to measure underscores the capacity of the cellular immune system
direct macromolecular interactions. to recognize a broader spectrum of pathogenic organ-
In vitro binding assays demonstrated that only low isms and molecules than previously believed.
MW PS-A interacted with HLA-DR2, a result suggesting
that processing is required for presentation. Further-
Experimental Proceduresmore, we found that this interaction was dependent
upon HLA-DM and low pH, supporting the lack of pre- Cell Lines and Culturing
sentation by B cells in the presence of BFA and chlo- C57BL/6 mouse splenocytes from PS-A-primed mice (50 g IP on
days 8 and 1) and human PBMCs were isolated with a Ficoll-roquine as well as previous studies showing no T cell
Hypaque gradient as before (Tzianabos et al., 2000). Cell prepara-activation mediated by BFA-treated APCs (Kalka-Moll
tions were enriched for T cells by nylon wool. For confocal studies,et al., 2002). Moreover, co-IP results conclusively show
human lymphoma B cell line Raji and MHCII/ Raji cells (RJ2.2.5;that only low MW ZPS antigen were presented by MHCII
(Accolla et al., 1985) were used. Processing studies used Raji cells,
proteins and that the production of NO is critical for the murine M12 B cells (gift from E. Kieff, Brigham & Women’s Hospital),
processing of ZPS molecules prior to MHCII loading. human THP-1 monocytes (ATCC), and mouse B1 B cells (WEHI-
231; ATCC). Cells were cultured in either RPMI1640 or Dulbecco’sThese data, obtained from live APCs, provide a critical
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Modified Eagle Medium (ATCC) supplemented with 10% fetal bovine 5.0 and 7.3 in A/PBS buffer and was compared to trypsin (Sigma,
St. Louis, Missouri).serum.(GIBCO, Grand Island, New York).
In vitro degradation was performed by incubation of [3H]-PSA
under various solution conditions overnight at 37C. DegradationZPS Purification
was assessed by Superose 12 chromatography.PS-A was purified from a mutant B. fragilis strain producing only
PS-A in its capsule (Krinos et al., 2001). Bacteria growth and PS-A
Binding Assayspurification were performed as previously described (Tzianabos et
CHO cells producing soluble HLA-DR2 (Gauthier et al., 1998) withal., 1992). The final PS-A sample was characterized by SDS-PAGE,
a peptide from myelin basic protein (residues 85–99) on the aminoH1-NMR spectroscopy, Western blots, and wavelength scans. The
terminus of the  subunit were used as a source of MHCII protein.final preparation was judged to be 
99% pure by these methods.
MAbs to HLA-DR were purified from HB-55 hybridoma medium and
conjugated to affinity resin. Cells were grown at high density in
ZPS Labeling
serum-free medium (HyQ SFM4CHO, HyClone, Logan, Utah), and
PS-A was oxidized with NaIO4 so that 20% of the galactofuranose secreted protein was purified from the spent medium using affinity
side chain sugar was modified to contain an aldehyde at the C5
chromatography and was judged to be 
99% homogeneous by
position. Hydrazide-linked AlexaFluor594 (Molecular Probes, Eu-
SDS-PAGE and Coomassie blue staining. Protein was digested with
gene, Oregon) and biotin (Pierce, Rockford, Illinois) tags were
thrombin (Sigma) for 1 hr to cleave the peptide bond holding the
attached to the aldehyde according to the manufacturer’s specifica-
peptide to the  chain, enabling antigen exchange and binding.
tions. For radiolabeling, the aldehyde was reduced by [3H]-NaBH4. Biotinylated intact PS-A (
100 kDa) or ozone-cleaved PS-A (15
kDa) was incubated at 5 M in ELISA plate wells (Immulon 2 HB,
ZPS Antigen Uptake, Colocalization, and Image Analysis Fisher Scientific, Pittsburgh, Pennsylvania) coated with either gly-
Texas Red conjugated dextran (70 kDa) and ovalbumin were from cine (negative control) or purified HLA-DR2 (100 ng/well) for 24 hr
Molecular Probes. Monoclonal mAbs (PharMingen, San Diego, Cali- at 37C with mild agitation in A/PBS. In some assays, purified soluble
fornia, except as indicated) to human LAMP-1 (clone H4A3), human HLA-DM (gift from S. DeWall, Harvard Medical School) (Mosyak et
HLA-DR2 (clone L243; purified from HB-55 hybridoma; ATCC), hu- al., 1998) was also added (1 g/well). Bound PS-A was detected
man HLA-DM (clone MaP.DM.1), murine I-Ad/I-Ed (clone 2G9), and with europium-conjugated streptavidin, DELFIA Enhancement
human (clone T10B9.1A-31) and murine (clone H57-597) TCR Buffer (according to the manufacturer’s specifications; Perkin-
were conjugated to AlexaFluor488 (Molecular Probes). Raji cells Elmer, Boston, Massachusetts), and time-resolved fluorescence
(106) were incubated with 50 g of conjugated PS-A for 3 hr at 37C measurements in a Wallac Victor2 plate fluorometer (Perkin-Elmer).
in a water-jacketed incubator with 5% CO2 and then fixed in 4% Background from the glycine negative controls at each condition
paraformaldehyde for 30 min at RT. Cells were incubated with anti- was subtracted from the raw data.
body for 30 min and then visualized with a Zeiss Pascal confocal
microscope (63 objective lens; Carl Zeiss, Thornwood, New York). Abscess Induction Studies
Cross-sectional histograms of the pixel intensities were created All mice were obtained from Jackson Laboratories (Bar Harbor,
from high-resolution confocal images by image analysis software Maine). Strains were as follows: WT mice, strain C57BL/6J, stock
(Diversity Database v. 2.2.0, BioRad, Hercules, California). Other 000664; CGD mice on C57BL/6 background, strain B6.129S6-
antigen controls (not shown) included ovalbumin, 70 kDa dextran, Cybbtm1Din, stock 002365 (Pollock et al., 1995); and iNOS/ mice
10 kDa dextran, 40 kDa dextran sulfate, and type 3 group B strepto- on C57BL/6 background, strain B6.129P2-Nos2tm1Lau, stock 002609
coccal capsular polysaccharide. Amounts incubated with Raji cells (Laubach et al., 1995). Abscess induction was perform as before
were equimolar to 50 g of PS-A. (Tzianabos et al., 1999), with live B. fragilis (108 cfu/injection) or
purified PS-A (50 g/mouse). Animals were examined for the pres-
ence of one or more abscesses 6 days after challenge.Drug Treatments
Raji cells were treated for 1 hr with colchicine (10 M), cytochalasin
D (20 M), BFA (100 nM), or chloroquine (200 g/ml) prior to incuba- Coimmunoprecipitations
tion with PS-A. Brefeldin A (2.5, 5.0, and 20 g/ml) was added 30 Spleens (n	 12) were harvested from either WT C57BL/6 or iNOS/
min before PS-A. For semiquantitative analysis, cells were manually mice. Mononuclear cells were incubated for 24 hr at 37C with 1 mg
counted for total cells and cells positive for colocalization in all of either intact (
100,000 kDa) or a mixture of high and low MW
images taken (n 
 5) for each drug treatment and concentration [3H]-PSA (
100,000 kDa to 10 kDa). Cells were then digested with
used. Drug-free controls were performed for comparison. Statistical papain (0.1 mg/ml papain; 10 mM Tris-HCl, pH 7.5; 1 mM EDTA; 1%
evaluation was performed with an unpaired Student’s t test at a 95% -mercaptoethanol) for 1 hr at 37C to release the MHCII proteins
confidence level (Prism v. 3.0, GraphPad, San Diego, California). from the plasma membrane (Wiman et al., 1982). The supernatants
were added to protein A-agarose beads (Sigma) containing 25 g
of mAb to either MHCII (clone 2G9, PharMingen, San Diego, Califor-In Vitro Processing Assays
nia) or LAMP-1 (clone 1D4B, PharMingen) and protease inhibitorAPCs (108) were cultured in the presence of 0.5 mg of [3H]-PSA for
cocktail (Sigma) and incubated overnight with mixing at 4C. The15 to 18 hr. at 37C to allow uptake and processing. Cells were
resin was boiled in 10% SDS with 10% -mercaptoethanol and 3 Mcollected and washed with PBS. Cell lysis was performed by pas-
NaCl for 20 min. The supernatants were analyzed by Superose 12sage through a 27 gauge needle in 250 mM sucrose with 50 mM
chromatography and fractions analyzed for radioactivity.Tris-HCl, pH 7.5. Microsomes were isolated for analysis of ingested
PS-A with centrifugation (Schroter et al., 1999). The pellet was then
digested with Pronase to eliminate contaminating protein. The pres- APC/T Cell Engagement
For dual-stained T cell engagement studies, T cell-enriched spleno-ence of microsomal markers (HLA-DM and LAMP-1) were verified
in non-Pronase digested pellets by ELISA (not shown). Microsomal cytes from PS-A-injected (50 g/animal, IP, days 7 and 1) WT
C57BL/6 mice (Jackson Labs) were incubated with unlabeled anti-PS-A was analyzed by molecular sieve chromatography on a Su-
perose 12 column in PBS using a BioRad FPLC (BioLogic HR, Bio- gen (staphylococcal enterotoxin A at 10 ng/ml, PS-A at 50 g/ml,
or medium-only control) for 3 days at 37C. The cell populationsRad). Fractions were assayed for radioactivity to determine the elu-
tion profile. were then transferred to poly-L lysine-coated slides and stained for
30 min at 4C with AlexaFluor594-conjugated mAbs to murineMicrosomal lysates not digested with Pronase were also assayed
for protease and glycosidase activity. Glycosidase activity was as- MHCII and AlexaFluor488 antibody to the TCR. Confocal images
were collected as described above. Tricolor T cell engagementsessed by incubation microsomal lysates with [3H]-PSA at pH 5.0
and 7.3 in a dual-buffered system (A/PBS; 50 mM sodium acetate, studies were done exactly as specified above, only using Alexa-
Fluor594-conjugated PS-A at 50 g/ml with AlexaFluor488 anti-50 mM sodium monobasic phosphate, 0.9% NaCl). Degradation was
determined by Superose 12 chromatography. For controls, protease body to murine MHCII and AlexaFluor633-conjugated antibody to
the TCR. In order to reduce confusion, the signal from PS-A wasactivity was measured in a casein assay (Molecular Probes) at pH
Cell
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assigned to the blue channel, murine MHCII to red, and TCR an immunodominant peptide of human myelin basic protein. Proc.
Natl. Acad. Sci. USA 95, 11828–11833.to green.
Kalka-Moll, W.M., Tzianabos, A.O., Wang, Y., Carey, V.J., Finberg,
Acknowledgments R.W., Onderdonk, A.B., and Kasper, D.L. (2000). Effect of molecular
size on the ability of zwitterionic polysaccharides to stimulate cellu-
We thank the NIH and the Ford Foundation for support (NIH/NIAID lar immunity. J. Immunol. 164, 719–724.
grants AI039576 and AI007061 to Dennis L. Kasper, AI52397 to Kalka-Moll, W.M., Tzianabos, A.O., Bryant, P.W., Niemeyer, M.,
Arthur O. Tzianabos, and a Ford Foundation postdoctoral fellowship Ploegh, H.L., and Kasper, D.L. (2002). Zwitterionic polysaccharides
to Brian A. Cobb). We thank Kai W. Wucherpfennig and Stephen stimulate T cells by MHC class II-dependent interactions. J. Immu-
DeWall for providing MHCII constructs. We also thank Drs. Colette nol. 169, 6149–6153.
Cywes and Robert Finberg for critical reading of this manuscript.
Kappler, J., White, J., Kozono, H., Clements, J., and Marrack, P.
(1994). Binding of a soluble alpha beta T-cell receptor to superanti-Received: August 7, 2003
gen/major histocompatibility complex ligands. Proc. Natl. Acad. Sci.Revised: April 13, 2004
USA 91, 8462–8466.Accepted: April 22, 2004
Kasper, D.L., Paoletti, L.C., Wessels, M.R., Guttormsen, H.K., Carey,Published: May 27, 2004
V.J., Jennings, H.J., and Baker, C.J. (1996). Immune response to type
III group B streptococcal polysaccharide-tetanus toxoid conjugateReferences
vaccine. J. Clin. Invest. 98, 2308–2314.
Abbas, A.K., Lichtman, A.H., and Pober, J.S. (2000). Cellular and Koh, S.D., Monaghan, K., Sergeant, G.P., Ro, S., Walker, R.L., San-
Molecular Immunology (New York: W.B. Saunders Company). ders, K.M., and Horowitz, B. (2001). TREK-1 regulation by nitric
oxide and cGMP-dependent protein kinase. An essential role inAccolla, R.S., Carra, G., Buchegger, F., Carrel, S., and Mach, J.P.
smooth muscle inhibitory neurotransmission. J. Biol. Chem. 276,(1985). The human Ia-associated invariant chain is synthesized in
44338–44346.Ia-negative B cell variants and is not expressed on the cell surface
of both Ia-negative and Ia-positive parental cells. J. Immunol. Krinos, C.M., Coyne, M.J., Weinacht, K.G., Tzianabos, A.O., Kasper,
134, 3265–3271. D.L., and Comstock, L.E. (2001). Extensive surface diversity of a
commensal microorganism by multiple DNA inversions. NatureAdorini, L., Ullrich, S.J., Appella, E., and Fuchs, S. (1990). Inhibition
414, 555–558.by brefeldin A of presentation of exogenous protein antigens to
MHC class II-restricted T cells. Nature 346, 63–66. Laubach, V.E., Shesely, E.G., Smithies, O., and Sherman, P.A. (1995).
Mice lacking inducible nitric oxide synthase are not resistant toBacci, S., Nakamura, T., and Streilein, J.W. (1996). Failed antigen
lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA 92,presentation after UVB radiation correlates with modifications of
10688–10692.Langerhans cell cytoskeleton. J. Invest. Dermatol. 107, 838–843.
Mosyak, L., Zaller, D.M., and Wiley, D.C. (1998). The structure ofBaker, C.J., Paoletti, L.C., Wessels, M.R., Guttormsen, H.K., Rench,
HLA-DM, the peptide exchange catalyst that loads antigen ontoM.A., Hickman, M.E., and Kasper, D.L. (1999). Safety and immunoge-
class II MHC molecules during antigen presentation. Immunity 9,nicity of capsular polysaccharide-tetanus toxoid conjugate vaccines
377–383.for group B streptococcal types Ia and Ib. J. Infect. Dis. 179,
142–150. Pier, G.B., and Elcock, M.E. (1984). Nonspecific immunoglobulin
synthesis and elevated IgG levels in rabbits immunized with mucoidBrubaker, J.O., Li, Q., Tzianabos, A.O., Kasper, D.L., and Finberg,
exopolysaccharide from cystic fibrosis isolates of PseudomonasR.W. (1999). Mitogenic activity of purified capsular polysaccharide
aeruginosa. J. Immunol. 133, 734–739.A from Bacteroides fragilis: differential stimulatory effect on mouse
and rat lymphocytes in vitro. J. Immunol. 162, 2235–2242. Pollock, J.D., Williams, D.A., Gifford, M.A., Li, L.L., Du, X., Fisherman,
Busch, R., Reich, Z., Zaller, D.M., Sloan, V., and Mellins, E.D. (1998). J., Orkin, S.H., Doerschuk, C.M., and Dinauer, M.C. (1995). Mouse
Secondary structure composition and pH-dependent conforma- model of X-linked chronic granulomatous disease, an inherited de-
tional changes of soluble recombinant HLA-DM. J. Biol. Chem. fect in phagocyte superoxide production. Nat. Genet. 9, 202–209.
273, 27557–27564. Riberdy, J.M., Newcomb, J.R., Surman, M.J., Barbosa, J.A., and
Choi, Y.H., Roehrl, M.H., Kasper, D.L., and Wang, J.Y. (2002). A Cresswell, P. (1992). HLA-DR molecules from an antigen-processing
unique structural pattern shared by T-cell-activating and abscess- mutant cell line are associated with invariant chain peptides. Nature
regulating zwitterionic polysaccharides. Biochemistry 41, 15144– 360, 474–477.
15151. Riese, R.J., Mitchell, R.N., Villadangos, J.A., Shi, G.P., Palmer, J.T.,
Chung, D.R., Kasper, D.L., Panzo, R.J., Chtinis, T., Grusby, M.J., Karp, E.R., De Sanctis, G.T., Ploegh, H.L., and Chapman, H.A. (1998).
Sayegh, M.H., and Tzianabos, A.O. (2003). CD4 T cells mediate Cathepsin S activity regulates antigen presentation and immunity.
abscess formation in intra-abdominal sepsis by an IL-17-dependent J. Clin. Invest. 101, 2351–2363.
mechanism. J. Immunol. 170, 1958–1963. Rotzschke, O., Lau, J.M., Hofstatter, M., Falk, K., and Strominger,
D’Souza, M.P., and August, J.T. (1986). A kinetic analysis of biosyn- J.L. (2002). A pH-sensitive histidine residue as control element for
thesis and localization of a lysosome-associated membrane glyco- ligand release from HLA-DR molecules. Proc. Natl. Acad. Sci. USA
protein. Arch. Biochem. Biophys. 249, 522–532. 99, 16946–16950.
Davies, G., and Henrissat, B. (1995). Structures and mechanisms of Rye, C.S., and Withers, S.G. (2000). Glycosidase mechanisms. Curr.
glycosyl hydrolases. Structure 3, 853–859. Opin. Chem. Biol. 4, 573–580.
Edmunds, N.J., and Marshall, J.M. (2003). The roles of nitric oxide Sanderson, F., Kleijmeer, M.J., Kelly, A., Verwoerd, D., Tulp, A.,
in dilating proximal and terminal arterioles of skeletal muscle during Neefjes, J.J., Geuze, H.J., and Trowsdale, J. (1994). Accumulation
systemic hypoxia. J. Vasc. Res. 40, 68–76. of HLA-DM, a regulator of antigen presentation, in MHC class II
compartments. Science 266, 1566–1569.Forman, H.J., and Torres, M. (2001). Redox signaling in macro-
phages. Mol. Aspects Med. 22, 189–216. Schroter, C.J., Braun, M., Englert, J., Beck, H., Schmid, H., and
Kalbacher, H. (1999). A rapid method to separate endosomes fromGantt, K.R., Goldman, T.L., McCormick, M.L., Miller, M.A., Jeronimo,
lysosomal contents using differential centrifugation and hypotonicS.M., Nascimento, E.T., Britigan, B.E., and Wilson, M.E. (2001). Oxi-
lysis of lysosomes. J. Immunol. Methods 227, 161–168.dative responses of human and murine macrophages during phago-
cytosis of Leishmania chagasi. J. Immunol. 167, 893–901. Shi, G.P., Munger, J.S., Meara, J.P., Rich, D.H., and Chapman, H.A.
(1992). Molecular cloning and expression of human alveolar macro-Gauthier, L., Smith, K.J., Pyrdol, J., Kalandadze, A., Strominger,
J.L., Wiley, D.C., and Wucherpfennig, K.W. (1998). Expression and phage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem.
267, 7258–7262.crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and
Polysaccharide Processing and MHCII Presentation
687
Shi, G.P., Villadangos, J.A., Dranoff, G., Small, C., Gu, L., Haley,
K.J., Riese, R., Ploegh, H.L., and Chapman, H.A. (1999). Cathepsin
S required for normal MHC class II peptide loading and germinal
center development. Immunity 10, 197–206.
Sloan, V.S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mel-
lins, E., and Zaller, D.M. (1995). Mediation by HLA-DM of dissociation
of peptides from HLA-DR. Nature 375, 802–806.
Svensson, M., Stockinger, B., and Wick, M.J. (1997). Bone marrow-
derived dendritic cells can process bacteria for MHC-I and MHC-II
presentation to T cells. J. Immunol. 158, 4229–4236.
Tsuji, S., Taniuchi, S., Hasui, M., Yamamoto, A., and Kobayashi, Y.
(2002). Increased nitric oxide production by neutrophils from pa-
tients with chronic granulomatous disease on trimethoprim-sulfa-
methoxazole. Nitric Oxide 7, 283–288.
Tzianabos, A.O., and Kasper, D.L. (2002). Role of T cells in abscess
formation. Curr. Opin. Microbiol. 5, 92–96.
Tzianabos, A.O., Pantosti, A., Baumann, H., Brisson, J.R., Jennings,
H.J., and Kasper, D.L. (1992). The capsular polysaccharide of Bacte-
roides fragilis comprises two ionically linked polysaccharides. J.
Biol. Chem. 267, 18230–18235.
Tzianabos, A.O., Onderdonk, A.B., Rosner, B., Cisneros, R.L., and
Kasper, D.L. (1993). Structural features of polysaccharides that in-
duce intra-abdominal abscesses. Science 262, 416–419.
Tzianabos, A.O., Onderdonk, A.B., Zaleznik, D.F., Smith, R.S., and
Kasper, D.L. (1994). Structural characteristics of polysaccharides
that induce protection against intra-abdominal abscess formation.
Infect. Immun. 62, 4881–4886.
Tzianabos, A.O., Russell, P.R., Onderdonk, A.B., Gibson, F.C., III,
Cywes, C., Chan, M., Finberg, R.W., and Kasper, D.L. (1999). IL-2
mediates protection against abscess formation in an experimental
model of sepsis. J. Immunol. 163, 893–897.
Tzianabos, A.O., Finberg, R.W., Wang, Y., Chan, M., Onderdonk,
A.B., Jennings, H.J., and Kasper, D.L. (2000). T cells activated by
zwitterionic molecules prevent abscesses induced by pathogenic
bacteria. J. Biol. Chem. 275, 6733–6740.
Tzianabos, A.O., Wang, J.Y., and Lee, J.C. (2001). Structural ratio-
nale for the modulation of abscess formation by Staphylococcus
aureus capsular polysaccharides. Proc. Natl. Acad. Sci. USA 98,
9365–9370.
Wang, Y., Kalka-Moll, W.M., Roehrl, M.H., and Kasper, D.L. (2000).
Structural basis of the abscess-modulating polysaccharide A2 from
Bacteroides fragilis. Proc. Natl. Acad. Sci. USA 97, 13478–13483.
Watts, C. (1997). Capture and processing of exogenous antigens for
presentation on MHC molecules. Annu. Rev. Immunol. 15, 821–850.
Watts, C., and Powis, S. (1999). Pathways of antigen processing
and presentation. Rev. Immunogenet. 1, 60–74.
Wiman, K., Claesson, L., Rask, L., Tragardh, L., and Peterson, P.A.
(1982). Purification and partial amino acid sequence of papain-solu-
bilized class II transplantation antigens. Biochemistry 21, 5351–
5358.
